Mouse Xpo5/2410004H11Rik/2700038C24Rik ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_028198.3)

Cat. No.: pGMPC001234
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse Xpo5/2410004H11Rik/2700038C24Rik Non-Viral expression plasmid (overexpression vector) for mouse Xpo5 overexpression in unique cell transient transfection and stable cell line development.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC001234
Gene Name Xpo5
Accession Number NM_028198.3
Gene ID 72322
Species Mouse
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 3615 bp
Gene Alias 2410004H11Rik,2700038C24Rik,Exp5,mKIAA1291,RanBp21
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 6xHis (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAGATGGAGCAAGTGAACGCGCTGTGCGAGGAGCTAGTGAAAGCGGTGACGGTCATGATGGACCCCAGCTCTACCCAGCGCTACCGGCTGGAAGCCCTCAAGTTTTGTGAAGAGTTTAAAGAAAAATGCCCTATCTGTGTTCCATGTGGCTTGAAGTTGGCTGAAAAAACACAAATTGCCATCGTCAGACATTTTGGCCTTCAGATCCTGGAGCATGTTGTCAAGTTTCGATGGAACAGCATGTCCCGATTGGAGAAGGTCTATCTGAAGAACAGTGTCATGGAGCTGATCGCAAATGGAACACTGAGGATTTTGGAGGAGGAGAACCACATTAAAGATGTTCTGTCTAGAATTGTGGTAGAGATGATCAAACGAGAGTGGCCACAGCACTGGCCTGACATGCTCATGGAGTTGGATACTCTCTTCAGGCAAGGGGAAACGCAGAGGGAGTTGGTGATGTTCATCCTTCTCCGACTGGCCGAGGATGTAGTGACCTTTCAGACGCTCCCCACTCAAAGAAGAAGGGATATTCAGCAAACATTGACGCAGAACATGGAAAGAATCTTGAATTTTCTACTCAATACGCTTCAGGAAAATGTAAACAAGTACCAACAAATGAAGACAGATTCATCTCAGGAGGCAGAGGCTCAAGCCAACTGTCGAGTAAGCGTGGCGGCCCTGAACACTCTAGCCGGCTACATTGACTGGGTATCTTTGAACCATATCACTGCCGAGAACTGTAAACTCGTGGAGACTCTGTGCCTGCTTCTCAATGAGCAGGAGCTGCAGTTGGGAGCCGCCGAGTGTCTGCTCATTGCAGTCAGCAGAAAAGGCAAGCTGGAGGACCGGAAGCGCTTGATGATCCTGTTTGGAGATGTCGCCATGCATTATATTCTCTCGGCCGCACAGACTGCAGATGGAGGAGGCTTGGTCGAAAAACACTACCTCTTCCTGAAGAGACTTTGTCAGGTGTTATGTGCACTGGGAAATCTGCTATGTGCACTGCTGGCCTTAGATGCTAACATACAAACACCTATAAACTTTGGAATGTACCTGGAATCTTTTCTTGCTTTCACAACCCATCCAAGTCAGTTTTTACGCTCTTCAACCCATATGACGTGGGGAGCCCTCTTCAGGCATGAAGTTCTGTCCCGTGATCCGGCACTGTTAGCAGTAATACCAAAATATCTTCGTGCTTCTATGACAAACTTGGTCAAGATGGGCTTTCCTTCTAAAACAGATAGCCCCAGCTGTGAATATTCCCGATTTGATTTCGATAGTGATGAGGACTTCAATGCTTTCTTCAACTCCTCCCGAGCCCAGCATGGAGAGGTGGTGAGGTGTGTGTGTCGACTGGATCCTAAGACTAGCTTCCAGATGGCGGCAGAATGGCTCAAGTATCAGCTGTCAGCTTCTATTGACACTGGACCTGTGAACTCATGTTCTACAGCTGGAACTGGAGAGGGAGGCTTCTGCTCCATCTTCTCACCTTCATATGTGCAGTGGGAAGCTATGACTTTTTTTTTGGAAAGTGTGATCAACCAGATGTTTCGAACACTAGACAAAGAAGAGCTCCCGGTTAGTGATGGGATAGAGCTGCTGCAGCTGGTGTTGAACTTTGAAATCAAGGATCCCCTCGTCCTGTCCTGCGTCCTCACTAATGTCTCAGCGCTCTTCCCATTTGTCACATACAAGCCTGCGTTCTTGCCCCAGGTCTTCTCTAAGCTCTTTTCATTTGTTACTTTTGAATCTGTTGGGGAAAGTAAGGCCCCCAGGACTCGGGCAGTCAGGAATGTAAGGAGACATGCTTGTTCCTCCATCAACAAGATGTGTCGGGACTACCCAGACCTTGTTCTGCCCAATTTTGACATGCTTTATAGCCACGTGAAGCAACTCCTCTCCAATGAGCTCCTCCTGACCCAGATGGAGAAGTGCGCCCTCATGGAAGCTCTGGTTCTCGTTAGCAACCAATTCAAGGATTATGAGCGGCAGAAGTTATTCCTAGAGGAGCTGATGGCACCGGTGGTCAACATCTGGCTTTCTGAAGAAATGTGCAGAGCGCTGTCAGATATTGACTCCTTCATTGCCTATGTGGGTGCTGATCTGAAAAGCTGTGACCCAGCTGTGGAGGATCCATGTGGCTTGAACCGTGCACGAATGAGCTTTTGTGTGTACAGCATCCTGGGGGTTATGAGACGCACTAGCTGGCCTTCCGACCTAGAAGAAGCCAAAGCTGGGGGCTTTGTGGTGGGCTACACACCCAGTGGAAATCCCATCTTCCGTAACCCCTGCACAGAGCAGATCCTCAGACTTCTCGACAATTTGCTTGCCCTTGTAAGAACTCACAATACTTTATATACACCGGAAATGCTAACGAAAATGGCAGAACCTTTCACCAAGGCTCTGGATATAGTTGAATCTGAAAAAACGGCAATATTAGGATTACCTCAGCCTCTCTTGGAATTCAACGACCACCCTGTCTATAGAACCACTCTGGAGAGGATGCAGCGGTTCTTTGGCATTCTCTATGAAAACTGTTACCATATCCTAGGGAAGGCAGGCCCTTCCATGCAGCAAGATTTCTACACTGTGGAGGACCTTGCTTCCCAGCTCCTTGGATCAGCTTTCGTCAACTTGAACAATATTCCTGACTTCCGGCTTAGATCTATGCTTCGTGTCTTCGTGAAGCCCCTCGTGCTCTTCTGCCCCTCAGAACACTATGAAACCCTGATATCTCCCATCCTTGGACCTCTCTTCACCTACCTCCACATGAGGCTCTCTCAGAAGTGGCATGTCATCAACCAGAGGAGCATCCTGTGTGGAGAAGATGAGATTGCAGAGGACAACCCCGAGTCTCAGGAAATGCTCGAGGAACAGCTGGTGAGGATGCTCACCCGAGAAGCCATGGACCTAATCATGGCTTGCTGTGTGTCGAAGAAGACTGCCGACCACACAGCCGCTCCCACTGCAGATGGAGATGATGAAGAGATGATGGCCACTGAAGTAGCCCCCTCGTCTGTGGTGGAGCTCACAGACCTGGGCAAATGCCTCATGAAGCACGAGGATGTCTGCACAGCACTGCTAATCACAGCATTTAATTCTCTGACCTGGAAGGACACACTGTCTTGCCAGAGGGCTACCACACAGCTCTGCTGGCCCCTCCTCAAACAGGTGATGTCTGGGACCCTGCTCGCAGACGCTGTCACTTGGCTTTTCACCAGTGTGCTGAAAGGACTGCAGATGCACGGGCAGCACGATGGGTGCATGGCTTCCCTGGTCCACTTGGCCTTCCAGATATACGAGGCGCTGCGCCCCAGGTACCTAGAGATAAGAGCAGTAATGGAGCAGATCCCTGAAATAAACAAGGAGTCTCTGGACCAATTTGACTGCAAGCTTTTAAACCCCTCCCTTCAAAAAGCAGCTGATAAACGACGGAAGGACCACTTCAAACGTCTAATCGCTGGCTGCATTGGGAAACCCTTGGGAGAACAGTTCCGAAAAGAAGTTCACATTAAGAACCTTCCCTGGCTTTTCAAAAAACCCAAACCAATGTTGGAGACAGAAGTGCTGGACAGTGAGGAGGGTGGACTGGCCACCATCTTTGAACCCTGA
ORF Protein Sequence MEMEQVNALCEELVKAVTVMMDPSSTQRYRLEALKFCEEFKEKCPICVPCGLKLAEKTQIAIVRHFGLQILEHVVKFRWNSMSRLEKVYLKNSVMELIANGTLRILEEENHIKDVLSRIVVEMIKREWPQHWPDMLMELDTLFRQGETQRELVMFILLRLAEDVVTFQTLPTQRRRDIQQTLTQNMERILNFLLNTLQENVNKYQQMKTDSSQEAEAQANCRVSVAALNTLAGYIDWVSLNHITAENCKLVETLCLLLNEQELQLGAAECLLIAVSRKGKLEDRKRLMILFGDVAMHYILSAAQTADGGGLVEKHYLFLKRLCQVLCALGNLLCALLALDANIQTPINFGMYLESFLAFTTHPSQFLRSSTHMTWGALFRHEVLSRDPALLAVIPKYLRASMTNLVKMGFPSKTDSPSCEYSRFDFDSDEDFNAFFNSSRAQHGEVVRCVCRLDPKTSFQMAAEWLKYQLSASIDTGPVNSCSTAGTGEGGFCSIFSPSYVQWEAMTFFLESVINQMFRTLDKEELPVSDGIELLQLVLNFEIKDPLVLSCVLTNVSALFPFVTYKPAFLPQVFSKLFSFVTFESVGESKAPRTRAVRNVRRHACSSINKMCRDYPDLVLPNFDMLYSHVKQLLSNELLLTQMEKCALMEALVLVSNQFKDYERQKLFLEELMAPVVNIWLSEEMCRALSDIDSFIAYVGADLKSCDPAVEDPCGLNRARMSFCVYSILGVMRRTSWPSDLEEAKAGGFVVGYTPSGNPIFRNPCTEQILRLLDNLLALVRTHNTLYTPEMLTKMAEPFTKALDIVESEKTAILGLPQPLLEFNDHPVYRTTLERMQRFFGILYENCYHILGKAGPSMQQDFYTVEDLASQLLGSAFVNLNNIPDFRLRSMLRVFVKPLVLFCPSEHYETLISPILGPLFTYLHMRLSQKWHVINQRSILCGEDEIAEDNPESQEMLEEQLVRMLTREAMDLIMACCVSKKTADHTAAPTADGDDEEMMATEVAPSSVVELTDLGKCLMKHEDVCTALLITAFNSLTWKDTLSCQRATTQLCWPLLKQVMSGTLLADAVTWLFTSVLKGLQMHGQHDGCMASLVHLAFQIYEALRPRYLEIRAVMEQIPEINKESLDQFDCKLLNPSLQKAADKRRKDHFKRLIAGCIGKPLGEQFRKEVHIKNLPWLFKKPKPMLETEVLDSEEGGLATIFEP

Reference




    Data / case study


    Click to get more Data / Case study about the product.







    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.